查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球无细胞蛋白合成（CFPS）市场（至2030年）依产品类别（细胞萃取系统、试剂盒、设备和服务）、工作流程、方法和应用划分
市场调查报告书
商品编码
1876444

全球无细胞蛋白合成（CFPS）市场（至2030年）依产品类别（细胞萃取系统、试剂盒、设备和服务）、工作流程、方法和应用划分

Cell-free Protein Synthesis Market by Offering (Cell Extract Systems, Kits, Instruments, Services), Workflow, Method, Application - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 309 Pages | 订单完成后即时交付

价格

无细胞蛋白合成（CFPS）市场预计将从 2025 年的 2.172 亿美元成长到 2030 年的 3.089 亿美元，预测期内复合年增长率为 7.3%。

调查范围
调查期 2024-2033
基准年 2024
预测期 2025-2030
单元 金额（美元）
部分 供应类别、工作流程、方法、用途、最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

该市场的成长受到以下因素的推动：对快速高效蛋白质生产的需求不断增长；重组无细胞系统的应用日益广泛；在合成生物学和药物发现领域的应用不断扩大；表达有毒和难以表达的蛋白质的需求；以及人工智能/机器学习在优化表达系统中的应用。

无细胞蛋白合成市场-IMG1

“按服务种类划分，CFPS 服务板块预计在预测期内将呈现最高的增长速度。”

由于对客製化蛋白质生产解决方案的需求不断增长、快速原型製作的需求日益迫切，以及学术机构和生物技术公司越来越多地采用外包服务，预计该细分市场在预测期内将实现最高增长。这些服务使研究人员无需投资昂贵的基础设施和专业知识即可利用先进的无细胞蛋白质合成（CFPS）技术。药物发现、合成生物学、疫苗开发和蛋白质组学等领域对合约蛋白质表现日益增长的兴趣推动了这一需求。此外，蛋白质标靶的复杂性日益增加，包括毒性蛋白、不稳定蛋白和膜蛋白，也推动了对能够快速且有效率地提供高品质蛋白质的专业服务供应商的需求。

“酵素工程是无性桿状细胞蛋白质合成的主要应用，推动了无细胞蛋白质合成市场的发展。”

2024年，酵素工程因其在合成生物学、代谢途径原型原型製作、定向进化和抗体开发等研究领域的广泛应用，成为无细胞蛋白质合成（CFPS）市场的主要驱动力。 CFPS无需活细胞即可快速测试和优化酶，使其成为设计具有更高性能、稳定性和特异性的酶的理想选择。它还有助于开发新型生物催化剂、改善代谢途径并加速药物研发。由于製药、生物技术及其他领域对快速、扩充性和灵活的蛋白质生产的需求不断增长，预计酶工程仍将是CFPS市场的主要驱动力。

预计亚太地区在预测期内将实现最高的复合年增长率。

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于该地区生物技术研发投资的增加、製药生产的扩张以及对合成生物学和精准医疗的日益重视。中国、日本、韩国和印度等国家透过政府资助、公私合营和国际合作显着提升了研发能力，从而创造了对无细胞蛋白合成（CFPS）技术的强劲需求。高通量蛋白生产、酵素工程和快速原型製作在药物发现、疫苗开发和诊断领域的日益普及，也持续推动市场成长。此外，该地区拥有丰富的熟练劳动力、低廉的生产成本、不断壮大的受託研究机构（CRO）以及不断完善的研究基础设施等优势，使其成为一个具有高成长潜力的市场。

本报告调查了全球无细胞蛋白质合成（CFPS）市场，并提供了市场概况、影响市场成长的各种因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测、按各个细分市场、地区/主要国家进行的详细分析、竞争格局以及主要企业的概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

  • 全球无细胞蛋白质合成市场概览
  • 北美：按应用和国家分類的无细胞蛋白质合成市场
  • 无细胞蛋白合成市场：地域成长机会
  • 未满足的需求和閒置频段
  • 相互关联的市场与跨产业机会
  • 新的经营模式和生态系统变化

第五章 市场概览

  • 市场动态
    • 司机
    • 传统活细胞与无细胞蛋白质合成系统（CFPS）的比较
    • 抑制因素
    • 机会
    • 任务
  • 产业趋势
  • 影响您业务的趋势/颠覆性因素
  • 定价分析
  • 技术分析
  • 技术/产品蓝图
  • 对永续性的承诺
  • 价值链分析
  • 生态系分析
  • 波特五力分析
  • 专利分析
  • 监管状态
  • 重大会议和活动
  • 客户状况与购买行为
  • 投资/资金筹措活动
  • 人工智慧/生成式人工智慧对无细胞蛋白合成市场的影响
  • 川普关税对无细胞蛋白合成市场的影响

第六章 无细胞蛋白合成市场依服务细分

  • 产品
    • 试剂盒和试剂
    • 细胞萃取物和表达系统
    • 装置
  • 服务

7. 按工作流程分類的无细胞蛋白质合成市场

  • 反应设定
  • 转录和翻译
  • 蛋白质折迭/转译后修饰（PTMS）
  • 模板准备
  • 回收和提炼
  • 检验与分析

8. 依方法分類的无细胞蛋白质合成市场

  • 转录/翻译耦合（TX-TL）
  • 转录和翻译

9. 无细胞蛋白合成市场依应用领域划分

  • 酵素工程
  • 高通量生产
  • 蛋白质-蛋白质相互作用
  • 蛋白质标记
  • 蛋白质纯化

第十章：依最终用户分類的无细胞蛋白质合成市场

  • 製药和生物技术公司
  • 学术研究机构
  • CRO/CDMO
  • 诊断公司

第十一章：按地区分類的无细胞蛋白质合成市场

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东
    • 海湾合作委员会国家
    • 其他的
    • 非洲

第十二章 竞争格局

  • 主要参与企业的策略/优势
  • 收入分析
  • 市占率分析
  • 公司评估矩阵：主要企业
  • 公司估值矩阵：Start-Ups/中小企业
  • 估值和财务指标
  • 品牌/产品对比
  • 竞争场景

第十三章：公司简介

  • 主要企业
    • NEW ENGLAND BIOLABS
    • PROMEGA CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
    • GENSCRIPT
    • TAKARA BIO INC.
    • LENIOBIO GMBH
    • CREATIVE BIOLABS
    • JENA BIOSCIENCE GMBH
    • BIOTECHRABBIT
    • BIODISCOVERY LLC
    • BIONEER CORPORATION
    • SINO BIOLOGICAL, INC.
    • KANEKA CORPORATION
    • GENECOPOEIA, INC.
    • CELLFREE SCIENCES CO., LTD.
  • 其他公司
    • VECTORBUILDER INC.
    • EXCELLGEN, INC.
    • CD BIOSYNSIS
    • CREATIVE BIOGENE
    • CUSABIO TECHNOLOGY
    • PROFACGEN
    • CAYMAN CHEMICAL
    • CAMBRIDGE ISOTOPE LABORATORIES, INC.
    • SYNTHELIS BIOTECH
    • SYNBIO TECHNOLOGIES
    • AMSBIO

第十四章附录

Product Code: BT 9571

The cell-free protein synthesis market is projected to reach USD 308.9 million by 2030, up from USD 217.2 million in 2025, with a CAGR of 7.3% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2033
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD million)
SegmentsOffering, Workflow, Method, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Growth in this market is driven by increasing demand for rapid and efficient protein production, rising adoption of reconstituted cell-free systems, expanding applications in synthetic biology and drug discovery, the need to express toxic and difficult-to-express proteins, and the integration of AI/ML to optimize expression systems.

Cell-free Protein Synthesis Market - IMG1

The cell-free protein synthesis services experienced the fastest growth during the forecast period of 2025 to 2030.

The cell-free protein synthesis market is divided into offerings such as products-like expression systems, reagents, and instruments-and services. During the forecast period, cell-free protein synthesis services are expected to grow the fastest due to increasing demand for customized protein production solutions, the need for quick prototyping, and the rising adoption of outsourcing by academic institutions and biotech companies. These services enable researchers to access advanced CFPS technologies without investing in expensive infrastructure or expertise. Growing interest in contract-based protein expression for drug discovery, synthetic biology, vaccine development, and proteomics is fueling demand. Additionally, the increasing complexity of protein targets, including toxic, unstable, or membrane proteins, is encouraging more organizations to turn to specialized service providers who can deliver high-quality proteins quickly and efficiently.

Enzyme engineering is a key application of cell-free protein synthesis, dominating the CFPS market.

The CFPS market, categorized by application, includes enzyme engineering, high-throughput protein production, protein labeling, protein purification, and studies of protein-protein interactions. In 2024, enzyme engineering dominated the CFPS application market due to its extensive use in research areas like synthetic biology, pathway prototyping, directed evolution, and therapeutic antibody development. CFPS enables researchers to rapidly test and optimize enzymes without the need for living cells, making it ideal for designing enzymes with enhanced performance, stability, and specificity. Additionally, it supports the creation of new biocatalysts, improves metabolic pathways, and accelerates drug discovery. The increasing demand for faster, scalable, and flexible protein production in pharmaceuticals, biotechnology, and other sectors ensures that enzyme engineering will remain the primary growth driver in the CFPS market.

The Asia Pacific region will experience the highest CAGR in the cell-free protein synthesis market during the forecast period of 2025 to 2030.

Asia Pacific is projected to have the highest CAGR in the cell-free protein synthesis market during the forecast period, fueled by increasing investments in biotechnology research, growing pharmaceutical manufacturing, and a rising focus on synthetic biology and precision medicine in the region. Countries such as China, Japan, South Korea, and India are significantly boosting their R&D capabilities through government funding, public-private partnerships, and international collaborations, creating strong demand for CFPS technologies. The growing adoption of high-throughput protein production, enzyme engineering, and rapid prototyping in drug discovery, vaccine development, and diagnostics continues to drive market growth. Additionally, the region benefits from a large, skilled workforce, lower production costs, expanding contract research organizations (CROs), and improving research infrastructure, establishing Asia Pacific as a high-potential growth market for cell-free protein synthesis.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
  • By Designation: (Managers) - 45%, (CXOs, Directors)- 30%, and (Executives) - 25%
  • By Region: North America- 40%, Europe - 25%, Asia Pacific - 20%, Rest of the World - 15%

Promega Corporation (US), New England Biolabs (US), Thermo Fisher Scientific Inc. (US), Genscript (US), and Takara Bio Inc. (Japan) are among the major players in the cell-free protein synthesis market.

The study provides a detailed competitive analysis of these key players in the cell-free protein synthesis market, including their company profiles, recent updates, and main market strategies.

Research Coverage:

This research report categorizes the cell-free protein synthesis market by offering (products such as Expression Systems, Reagents, and Instruments), services, workflow stages (Template preparation, Reaction setup, Transcription and translation, Protein folding and post-translational modification, Recovery and purification, Validation and analysis), method (Coupled Transcription-Translation, Only Translation), application (Enzyme Engineering, High-Throughput Production, Protein Labeling, Protein Purification, Protein-Protein Interaction), end user (academic and research institutes, pharmaceutical and biotechnology companies, others), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The report offers detailed information on key factors affecting the growth of the cell-free protein synthesis market, including drivers, trends, challenges, and opportunities. A comprehensive analysis of major industry players has been conducted to provide insights into their business profiles, products or services offered, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments such as new product launches and acquisitions within the cell-free protein synthesis market.

Key Benefits of Buying the Report:

The report will assist market leaders and newcomers by offering close estimates of revenue figures for the overall cell-free protein synthesis market and its segments. It will also help stakeholders better understand the competitive landscape and gain insights to more effectively position their business and develop appropriate go-to-market strategies. This report will allow stakeholders to grasp the market's current state and provide information on key drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (Increasing demand for rapid protein synthesis in research and pharma, growing demand for toxic and difficult-to-express proteins, integration of AI/ML for protein engineering using CFPS), restraints (high cost of essential reagents), opportunities (integration of cell-free technology in biosensors development, commercial-scale validation of cell-free protein expression) and challenges (Inability to fully replicate complex mammalian post-translational modifications) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products/services in the cell-free protein synthesis market
  • Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-free protein synthesis market
  • Competitive Assessment: In-depth assessment of market share, growth strategies of leading players like New England Biolabs (US), Thermo Fisher Scientific Inc. (US), Takara Bio, Inc. (Japan), and Promega Corporation (US), among others, in the cell-free protein synthesis market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
      • 2.1.2.2 Key objectives of primary research
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET ESTIMATION, 2024
      • 2.2.1.1 Company revenue analysis (bottom-up approach)
      • 2.2.1.2 MnM repository analysis
      • 2.2.1.3 Primary research
        • 2.2.1.3.1 Insights from primary experts
    • 2.2.2 SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 DATA TRIANGULATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

  • 3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
  • 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS IN CELL-FREE PROTEIN SYNTHESIS MARKET
  • 3.3 DISRUPTIVE TRENDS SHAPING CELL-FREE PROTEIN SYNTHESIS MARKET
  • 3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS

4 PREMIUM INSIGHTS

  • 4.1 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET SNAPSHOT
  • 4.2 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION AND COUNTRY, 2024
  • 4.3 CELL-FREE PROTEIN SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 UNMET NEEDS & WHITE SPACES
  • 4.5 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.6 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for rapid protein synthesis for research and therapeutic applications
      • 5.2.1.2 Momentum from biologics/ADC pipelines adopting CFPS for site-specific conjugation
      • 5.2.1.3 Ability to express difficult/complex proteins
    • 5.2.2 COMPARISON OF CONVENTIONAL LIVE CELLS AND CFPS SYSTEMS
    • 5.2.3 RESTRAINTS
      • 5.2.3.1 High cost of essential reagents
    • 5.2.4 OPPORTUNITIES
      • 5.2.4.1 Integration of cell-free technology in biosensor development
      • 5.2.4.2 Role in precision/personalized medicine
    • 5.2.5 CHALLENGES
      • 5.2.5.1 Inability to fully replicate complex mammalian post-translational modifications
      • 5.2.5.2 Concerns regarding scaling up
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 AI-GUIDED PROTEIN DESIGN PAIRED WITH CFPS FOR FASTER DISCOVERY
    • 5.3.2 SCALE-UP VIA CDMO PARTNERSHIPS TOWARD GMP READINESS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER
    • 5.5.2 AVERAGE SELLING PRICE RANGE OF KEY PRODUCTS, BY REGION
    • 5.5.3 FACTORS IMPACTING CELL-FREE PROTEIN SYNTHESIS PRODUCT PRICING
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 Cell-free protein synthesis (CFPS)
      • 5.6.1.2 Coupled transcription/translation
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 Synthetic DNA/mRNA & IVT capping-tailing
      • 5.6.2.2 Membrane mimetics for CFPS
    • 5.6.3 ADJACENT TECHNOLOGIES
      • 5.6.3.1 Recombinant DNA Technology
  • 5.7 TECHNOLOGY/PRODUCT ROADMAP
  • 5.8 SUSTAINABILITY INITIATIVES
  • 5.9 VALUE CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
    • 5.10.1 CELL-FREE PROTEIN SYNTHESIS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • 5.11 PORTER'S FIVE FORCES ANALYSIS
    • 5.11.1 THREAT OF NEW ENTRANTS
    • 5.11.2 THREAT OF SUBSTITUTES
    • 5.11.3 BARGAINING POWER OF SUPPLIERS
    • 5.11.4 BARGAINING POWER OF BUYERS
    • 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 PATENT ANALYSIS
    • 5.12.1 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR CELL- FREE PROTEIN SYNTHESIS PATENTS
    • 5.12.2 LIST OF KEY PATENTS
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 REGULATORY FRAMEWORK
    • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.13.2.1 North America
      • 5.13.2.2 Europe
      • 5.13.2.3 Asia Pacific
      • 5.13.2.4 Rest of the World
  • 5.14 KEY CONFERENCES & EVENTS
  • 5.15 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA FOR CELL-FREE PROTEIN SYNTHESIS PRODUCTS
    • 5.15.3 ADOPTION BARRIER AND INTERNAL FRICTION
  • 5.16 INVESTMENT/FUNDING ACTIVITY
  • 5.17 IMPACT OF AI/GEN AI ON CELL-FREE PROTEIN SYNTHESIS MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 AI USE CASES
    • 5.17.3 FUTURE OF GENERATIVE AI IN DRUG DEVELOPMENT ECOSYSTEM
  • 5.18 IMPACT OF 2025 TRUMP TARIFF ON CELL-FREE PROTEIN SYNTHESIS MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 IMPACT ON REGION
      • 5.18.4.1 North America
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USERS
      • 5.18.5.1 Pharmaceutical & biotechnology companies
      • 5.18.5.2 Academic & research institutes
      • 5.18.5.3 CROs and CDMOs
      • 5.18.5.4 Diagnostic companies

6 CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    • 6.2.1 KITS & REAGENTS
      • 6.2.1.1 Increasing adoption in academic and commercial R&D to aid growth
    • 6.2.2 CELL EXTRACTS & EXPRESSION SYSTEMS
      • 6.2.2.1 Wheat germ
      • 6.2.2.2 Rabbit reticulocyte
      • 6.2.2.3 Mammalian
      • 6.2.2.4 Insect
      • 6.2.2.5 Plant/algal systems
    • 6.2.3 INSTRUMENTS
  • 6.3 SERVICES

7 CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW

  • 7.1 INTRODUCTION
  • 7.2 REACTION SETUP
    • 7.2.1 USE OF CORE EXTRACTS IN THIS FOUNDATIONAL WORKFLOW STEP TO ACCELERATE ADOPTION
  • 7.3 TRANSCRIPTION & TRANSLATION
    • 7.3.1 STRONG ADOPTION OF COUPLED TX/TL TO SUPPORT GROWTH
  • 7.4 PROTEIN FOLDING/POST-TRANSLATIONAL MODIFICATIONS (PTMS)
    • 7.4.1 FOCUSING SHIFT TOWARDS COMPLEX TARGETS TO DRIVE SPENDING
  • 7.5 TEMPLATE PREPARATION
    • 7.5.1 GROWTH IN OUTSOURCED AND IN-HOUSE DNA SYNTHESIS TO DRIVE GROWTH
  • 7.6 RECOVERY & PURIFICATION
    • 7.6.1 READY-TO-RUN PURIFICATION MODULES CAN HELP VENDORS DIFFERENTIATE IN THE MARKET
  • 7.7 VALIDATION & ANALYSIS
    • 7.7.1 IMPORTANT STEP TO CONFIRM EXPRESSION, PURITY, IDENTITY, AND FUNCTION, ALLOWING TEAMS TO MAKE GO/NO-GO DECISIONS

8 CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD

  • 8.1 INTRODUCTION
  • 8.2 COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD
    • 8.2.1 METHOD ENABLING SIMULTANEOUS SYNTHESIS OF MRNA AND PROTEIN IN SINGLE REACTION
  • 8.3 TRANSCRIPTION & TRANSLATION
    • 8.3.1 TWO-STEP APPROACH SHORTENED DESIGN-TO-DATA PROCESS WHILE PROVIDING TIGHTER CONTROL OVER PRODUCT QUALITY

9 CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 ENZYME ENGINEERING
    • 9.2.1 RISING DEMAND FOR GREENER CHEMISTRIES TO AID GROWTH
  • 9.3 HIGH THROUGHPUT PRODUCTION
    • 9.3.1 HT CFPS SET TO BECOME THE DEFAULT ENGINE FOR PARALLEL PROTOTYPING AND RAPID METHOD TRANSFER INTO DOWNSTREAM MANUFACTURING
  • 9.4 PROTEIN-PROTEIN INTERACTION
    • 9.4.1 GROWING STUDIES DEMANDING PPI UNDERSTANDING AND COMPATIBILITY OF CFPS WITH MULTIPLEXED FORMATS TO AID GROWTH
  • 9.5 PROTEIN LABELING
    • 9.5.1 DEMAND FOR SITE-SPECIFIC TAGS, AND RAPID ANALYTICS TO ACCELERATE ADOPTION
  • 9.6 PROTEIN PURIFICATION
    • 9.6.1 RISE IN DEMAND FOR RAPID ACCESS TO PURIFIED PROTEINS TO SUPPORT GROWTH

10 CELL-FREE PROTEIN SYNTHESIS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 GROWING DEMAND FOR COMPRESSING TIMELINES AND EXPANDING COMPLEX BIOLOGICS TO DRIVE GROWTH
  • 10.3 ACADEMIC RESEARCH INSTITUTES
    • 10.3.1 INCREASING DEMAND FOR INNOVATIVE RESEARCH SOLUTIONS TO SUPPORT GROWTH
  • 10.4 CROS AND CDMOS
    • 10.4.1 FASTER STUDY CYCLES, AND STREAMLINING STUDY STARTS TO DRIVE SEGMENT
  • 10.5 DIAGNOSTIC COMPANIES
    • 10.5.1 GROWING INTEREST IN CFPS-BASED DIAGNOSTICS FOR PATHOGEN OR BIOMARKER DETECTION TO SUPPORT GROWTH

11 CELL-FREE PROTEIN SYNTHESIS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Rising approvals of protein-based therapies and increasing investments in R&D to support growth
    • 11.2.2 CANADA
      • 11.2.2.1 Government funding for research and innovation to support market growth
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Presence of major research institutes and pharmaceutical companies to support growth
    • 11.3.2 UK
      • 11.3.2.1 Strong commercial support for research & development work by government, especially in life sciences, to drive growth
    • 11.3.3 FRANCE
      • 11.3.3.1 Rise in proteomics research in France to support growth
    • 11.3.4 ITALY
      • 11.3.4.1 Growth in Italian market to be driven by increase in life science research projects
    • 11.3.5 SPAIN
      • 11.3.5.1 Presence of established network of research centers and universities, with collaborations in biomedicine & health and physical sciences & engineering, to support growth
    • 11.3.6 REST OF EUROPE (ROE)
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 Growth in proteomics R&D and growing pharmaceutical industry to support growth
    • 11.4.2 JAPAN
      • 11.4.2.1 Increasing protein-based research to support market growth
    • 11.4.3 INDIA
      • 11.4.3.1 Increasing drug development outsourcing to support market growth
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 Growing precision medicine research to offer significant growth opportunities in Australia
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Advancements in biopharmaceutical research and the development of novel therapies to support market growth
    • 11.4.6 REST OF ASIA PACIFIC (ROAPAC)
  • 11.5 LATIN AMERICA
    • 11.5.1 BRAZIL
      • 11.5.1.1 Industrial investment in protein sector to support market growth
    • 11.5.2 MEXICO
      • 11.5.2.1 Growth in biotechnology and pharmaceutical sectors to support growth
    • 11.5.3 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST
    • 11.6.1 GCC COUNTRIES
    • 11.6.2 REST OF MIDDLE EAST
    • 11.6.3 AFRICA
      • 11.6.3.1 Government investments in healthcare to drive market growth in region

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET
  • 12.3 REVENUE ANALYSIS, 2022-2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Regional footprint
      • 12.5.5.3 Offering footprint
      • 12.5.5.4 Method footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS
    • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYERS
    • 13.2.1 NEW ENGLAND BIOLABS
      • 13.2.1.1 Business overview
      • 13.2.1.2 Products/ Services offered
      • 13.2.1.3 Recent developments
        • 13.2.1.3.1 Expansions
      • 13.2.1.4 MnM view
        • 13.2.1.4.1 Key strengths
        • 13.2.1.4.2 Strategic choices
        • 13.2.1.4.3 Weaknesses and competitive threats
    • 13.2.2 PROMEGA CORPORATION
      • 13.2.2.1 Business overview
      • 13.2.2.2 Products/ Services offered
      • 13.2.2.3 MnM view
        • 13.2.2.3.1 Key strengths
        • 13.2.2.3.2 Strategic choices
        • 13.2.2.3.3 Weaknesses and competitive threats
    • 13.2.3 THERMO FISHER SCIENTIFIC INC.
      • 13.2.3.1 Business overview
      • 13.2.3.2 Products/ Services offered
      • 13.2.3.3 Recent developments
        • 13.2.3.3.1 Deals
      • 13.2.3.4 MnM view
        • 13.2.3.4.1 Key strengths
        • 13.2.3.4.2 Strategic choices
        • 13.2.3.4.3 Weaknesses and competitive threats
    • 13.2.4 GENSCRIPT
      • 13.2.4.1 Business overview
      • 13.2.4.2 Products/ Services offered
    • 13.2.5 TAKARA BIO INC.
      • 13.2.5.1 Business overview
      • 13.2.5.2 Products/ Services offered
    • 13.2.6 LENIOBIO GMBH
      • 13.2.6.1 Business overview
      • 13.2.6.2 Products/ Services offered
      • 13.2.6.3 Recent developments
        • 13.2.6.3.1 Deals
        • 13.2.6.3.2 Other developments
    • 13.2.7 CREATIVE BIOLABS
      • 13.2.7.1 Business overview
      • 13.2.7.2 Products/ Services offered
    • 13.2.8 JENA BIOSCIENCE GMBH
      • 13.2.8.1 Business overview
      • 13.2.8.2 Products/ Services offered
    • 13.2.9 BIOTECHRABBIT
      • 13.2.9.1 Business overview
      • 13.2.9.2 Products/ Services offered
    • 13.2.10 BIODISCOVERY LLC
      • 13.2.10.1 Business overview
      • 13.2.10.2 Products/ Services offered
      • 13.2.10.3 Recent developments
        • 13.2.10.3.1 Product launches
        • 13.2.10.3.2 Deals
    • 13.2.11 BIONEER CORPORATION
      • 13.2.11.1 Business overview
      • 13.2.11.2 Products/ Services offered
    • 13.2.12 SINO BIOLOGICAL, INC.
      • 13.2.12.1 Business overview
      • 13.2.12.2 Products/ Services offered
      • 13.2.12.3 Recent developments
        • 13.2.12.3.1 Deals
    • 13.2.13 KANEKA CORPORATION
      • 13.2.13.1 Business overview
      • 13.2.13.2 Products/ Services offered
      • 13.2.13.3 Recent developments
        • 13.2.13.3.1 Product launches
    • 13.2.14 GENECOPOEIA, INC.
      • 13.2.14.1 Business overview
      • 13.2.14.2 Products/ Services offered
    • 13.2.15 CELLFREE SCIENCES CO., LTD.
      • 13.2.15.1 Business overview
      • 13.2.15.2 Products/ Services offered
      • 13.2.15.3 Recent developments
        • 13.2.15.3.1 Deals
  • 13.3 OTHER PLAYERS
    • 13.3.1 VECTORBUILDER INC.
    • 13.3.2 EXCELLGEN, INC.
    • 13.3.3 CD BIOSYNSIS
    • 13.3.4 CREATIVE BIOGENE
    • 13.3.5 CUSABIO TECHNOLOGY
    • 13.3.6 PROFACGEN
    • 13.3.7 CAYMAN CHEMICAL
    • 13.3.8 CAMBRIDGE ISOTOPE LABORATORIES, INC.
    • 13.3.9 SYNTHELIS BIOTECH
    • 13.3.10 SYNBIO TECHNOLOGIES
    • 13.3.11 AMSBIO

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 CELL-FREE PROTEIN SYNTHESIS MARKET: RISK ANALYSIS
  • TABLE 4 CELL-FREE PROTEIN SYNTHESIS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS
  • TABLE 5 CELL-FREE PROTEIN SYNTHESIS MARKET: IMPACT ANALYSIS
  • TABLE 6 COMPARISON OF CONVENTIONAL LIVE CELLS AND CFPS SYSTEMS
  • TABLE 7 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER, 2024 (USD)
  • TABLE 8 AVERAGE SELLING PRICE RANGE OF KEY PRODUCTS, BY REGION, 2024-2025 (USD)
  • TABLE 9 CELL-FREE PROTEIN SYNTHESIS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 10 CELL-FREE PROTEIN SYNTHESIS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 11 CELL-FREE PROTEIN SYNTHESIS MARKET: DETAILED ANALYSIS OF KEY PATENTS, 2023-2025
  • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 CELL-FREE PROTEIN SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025-2026
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • TABLE 18 BUYING CRITERIA FOR CELL-FREE PROTEIN SYNTHESIS PRODUCTS, BY END USER
  • TABLE 19 CELL-FREE PROTEIN SYNTHESIS: ADOPTION BARRIER & INTERNAL FRICTION
  • TABLE 20 CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERINGS, 2023-2030 (USD MILLION)
  • TABLE 21 CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 22 CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 23 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 24 EUROPE: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 26 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS PRODUCTS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 28 CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 EUROPE: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS KITS & REAGENTS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 34 CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 EUROPE: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 MIDDLE EAST: CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 40 WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 NORTH AMERICA: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 EUROPE: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 LATIN AMERICA: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 MIDDLE EAST: WHEAT GERM CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 46 RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 NORTH AMERICA: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 EUROPE: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 LATIN AMERICA: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 MIDDLE EAST: RABBIT RETICULOCYTE CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 52 MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 NORTH AMERICA: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 EUROPE: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 LATIN AMERICA: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 MIDDLE EAST: MAMMALIAN CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 58 INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 EUROPE: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024-2033 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 LATIN AMERICA: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 MIDDLE EAST: INSECT CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 64 PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY REGION, 2024-2033 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024-2033 (USD MILLION)
  • TABLE 66 EUROPE: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024-2033 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2024-2033 (USD MILLION)
  • TABLE 68 LATIN AMERICA: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 MIDDLE EAST: PLANT/ALGAL CELL-FREE PROTEIN EXTRACTS AND EXPRESSION SYSTEMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 70 CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 71 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 EUROPE: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS INSTRUMENTS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 76 CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 EUROPE: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS SERVICES MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 82 CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 83 CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 EUROPE: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 LATIN AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 MIDDLE EAST: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 89 CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 LATIN AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 94 MIDDLE EAST: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 95 CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 96 NORTH AMERICA: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 EUROPE: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 LATIN AMERICA: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 MIDDLE EAST: CELL-FREE PROTEIN FOLDING/PTMS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 101 CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 102 NORTH AMERICA: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 EUROPE: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 LATIN AMERICA: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 MIDDLE EAST: CELL-FREE PROTEIN TEMPLATE PREPARATION MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 107 CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 EUROPE: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 LATIN AMERICA: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 MIDDLE EAST: CELL-FREE PROTEIN RECOVERY & PURIFICATION MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 113 CELL-FREE PROTEIN VALIDATION AND ANALYSIS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 EUROPE: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2024-2033 (USD MILLION)
  • TABLE 117 LATIN AMERICA: CELL-FREE PROTEIN ENZYME ENGINEERING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 CELL-FREE PROTEIN VALIDATION AND ANALYSIS MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 119 CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 120 CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 EUROPE: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 MIDDLE EAST: CELL-FREE PROTEIN COUPLED TRANSCRIPTION/TRANSLATION (TX-TL) METHOD MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 126 CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 127 NORTH AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 EUROPE: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 LATIN AMERICA: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 MIDDLE EAST: CELL-FREE PROTEIN TRANSCRIPTION & TRANSLATION MARKET, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 132 CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2024-2033 (USD MILLION)
  • TABLE 133 CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 135 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN ENZYME ENGINEERING, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 139 CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN HIGH THROUGHPUT PRODUCTION, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 145 CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN-PROTEIN INTERACTION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 147 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PROTEIN-PROTEIN INTERACTION, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 151 CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 152 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 153 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 155 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN LABELING, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 157 CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 158 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 159 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 161 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 162 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET IN PROTEIN PURIFICATION, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 163 CELL-FREE PROTEIN SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 164 CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 165 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 166 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 170 CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 171 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 172 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 176 CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 178 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR CROS AND CDMOS, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 182 CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 183 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 184 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET FOR DIAGNOSTIC COMPANIES, BY SUBREGION, 2023-2030 (USD MILLION)
  • TABLE 188 CELL-FREE PROTEIN SYNTHESIS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 189 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 190 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 191 NORTH AMERICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 193 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 194 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 195 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 196 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 197 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 198 US: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 200 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 201 US: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 202 US: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 203 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 204 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 205 CANADA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 207 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 208 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 209 CANADA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 210 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 211 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 212 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY CELL EXTRACTS & EXPRESSION SYSTEM, 2023-2030 (USD MILLION)
  • TABLE 213 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 214 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 215 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 216 EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 217 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 218 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 219 GERMANY: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 221 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 222 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 223 GERMANY: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 224 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 225 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 226 UK: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 228 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 229 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 230 UK: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 231 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 232 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 233 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY CELL EXTRACTS & EXPRESSION SYSTEM, 2023-2030 (USD MILLION)
  • TABLE 234 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 235 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 236 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 237 FRANCE: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 238 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 239 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 240 ITALY: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 241 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 242 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 243 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 244 ITALY: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 245 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 246 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 247 SPAIN: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 248 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 249 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 250 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 251 SPAIN: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 252 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 253 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 254 REST OF EUROPE: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 256 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 257 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 258 REST OF EUROPE: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 265 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 266 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 267 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 268 CHINA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 270 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 271 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 272 CHINA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 273 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 274 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 275 JAPAN: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 277 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 278 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 279 JAPAN: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 280 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 281 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 282 INDIA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 283 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 284 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 285 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 286 INDIA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 287 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 288 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 289 AUSTRALIA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 290 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 291 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2024-2033 (USD MILLION)
  • TABLE 292 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 293 AUSTRALIA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 294 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 295 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 296 SOUTH KOREA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 297 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 298 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 299 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 300 SOUTH KOREA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 301 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 302 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 303 REST OF ASIA PACIFIC: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 304 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 305 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 306 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 307 REST OF ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 308 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 309 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 310 LATIN AMERICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 311 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 312 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 313 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 314 LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 315 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 316 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 317 BRAZIL: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2024-2033 (USD MILLION)
  • TABLE 318 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2024-2033 (USD MILLION)
  • TABLE 319 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 320 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 321 BRAZIL: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 322 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 323 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 324 MEXICO: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 325 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 326 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 327 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 328 MEXICO: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 329 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 330 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 332 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 333 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 334 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 335 REST OF LATIN AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 336 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 337 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2024-2033 (USD MILLION)
  • TABLE 338 MIDDLE EAST: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 340 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 341 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 342 MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 343 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 344 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 345 GCC COUNTRIES: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 346 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 347 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 350 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 351 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 352 REST OF MIDDLE EAST: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 353 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 354 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 355 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 356 REST OF MIDDLE EAST: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 357 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 358 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 359 AFRICA: CELL-FREE PROTEIN EXTRACTS & EXPRESSION SYSTEMS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 360 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2023-2030 (USD MILLION)
  • TABLE 361 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2023-2030 (USD MILLION)
  • TABLE 362 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 363 AFRICA: CELL-FREE PROTEIN SYNTHESIS MARKET, END USER, 2023-2030 (USD MILLION)
  • TABLE 364 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 365 EUROPE: KEY MACROECONOMIC INDICATORS
  • TABLE 366 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 367 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 368 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
  • TABLE 369 AFRICA: KEY MACRO INDICATORS
  • TABLE 370 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET, JANUARY 2021-OCTOBER 2025
  • TABLE 371 CELL-FREE PROTEIN SYNTHESIS MARKET: DEGREE OF COMPETITION
  • TABLE 372 CELL-FREE PROTEIN SYNTHESIS MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 373 CELL-FREE PROTEIN SYNTHESIS MARKET: OFFERING FOOTPRINT, 2024
  • TABLE 374 CELL-FREE PROTEIN SYNTHESIS MARKET: METHOD FOOTPRINT, 2024
  • TABLE 375 CRO SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS, 2024
  • TABLE 376 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERINGS AND REGION
  • TABLE 377 CELL-FREE PROTEIN SYNTHESIS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-OCTOBER 2025
  • TABLE 378 CELL-FREE PROTEIN SYNTHESIS MARKET: DEALS, JANUARY 2021-OCTOBER 2025
  • TABLE 379 CELL-FREE PROTEIN SYNTHESIS MARKET: EXPANSIONS, JANUARY 2021-OCTOBER 2025
  • TABLE 380 CELL-FREE PROTEIN SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2025
  • TABLE 381 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 382 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
  • TABLE 383 NEW ENGLAND BIOLABS: EXPANSIONS
  • TABLE 384 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 385 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 386 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 387 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 388 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 389 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 390 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 391 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 392 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 393 LENIOBIO GMBH: COMPANY OVERVIEW
  • TABLE 394 LENIOBIO GMBH: PRODUCTS/SERVICES OFFERED
  • TABLE 395 LENIOBIO GMBH: DEALS
  • TABLE 396 LENIOBIO GMBH: OTHER DEVELOPMENTS
  • TABLE 397 CREATIVE BIOLABS: COMPANY OVERVIEW
  • TABLE 398 CREATIVE BIOLABS: PRODUCTS/SERVICES OFFERED
  • TABLE 399 JENA BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 400 JENA BIOSCIENCE GMBH: PRODUCTS/SERVICES OFFERED
  • TABLE 401 BIOTECHRABBIT: COMPANY OVERVIEW
  • TABLE 402 BIOTECHRABBIT: PRODUCTS/SERVICES OFFERED
  • TABLE 403 BIODISCOVERY LLC: COMPANY OVERVIEW
  • TABLE 404 BIODISCOVERY LLC: PRODUCTS/SERVICES OFFERED
  • TABLE 405 BIODISCOVERY LLC: PRODUCT LAUNCHES
  • TABLE 406 BIODISCOVERY LLC: DEALS
  • TABLE 407 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 408 BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 409 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW
  • TABLE 410 SINO BIOLOGICAL, INC.: SERVICES OFFERED
  • TABLE 411 SINO BIOLOGICAL, INC.: DEALS
  • TABLE 412 KANEKA CORPORATION: COMPANY OVERVIEW
  • TABLE 413 KANEKA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 414 KANEKA CORPORATION: PRODUCT LAUNCHES
  • TABLE 415 GENECOPOEIA, INC.: COMPANY OVERVIEW
  • TABLE 416 GENECOPOEIA, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 417 CELLFREE SCIENCES CO., LTD.: COMPANY OVERVIEW
  • TABLE 418 CELLFREE SCIENCES CO., LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 419 CELLFREE SCIENCES CO., LTD.: DEALS
  • TABLE 420 VECTORBUILDER INC.: COMPANY OVERVIEW
  • TABLE 421 EXCELLGEN, INC.: COMPANY OVERVIEW
  • TABLE 422 CD BIOSYNSIS: COMPANY OVERVIEW
  • TABLE 423 CREATIVE BIOGENE: COMPANY OVERVIEW
  • TABLE 424 CUSABIO TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 425 PROFACGEN: COMPANY OVERVIEW
  • TABLE 426 CAYMAN CHEMICAL: COMPANY OVERVIEW
  • TABLE 427 CAMBRIDGE ISOTOPE LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 428 SYNTHELIS BIOTECH: COMPANY OVERVIEW
  • TABLE 429 SYNBIO TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 430 AMSBIO: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 CELL-FREE PROTEIN SYNTHESIS MARKET SEGMENTATION
  • FIGURE 2 CELL-FREE PROTEIN SYNTHESIS MARKET SEGMENTATION
  • FIGURE 3 CELL-FREE PROTEIN SYNTHESIS MARKET: RESEARCH DESIGN
  • FIGURE 4 CELL-FREE PROTEIN SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
  • FIGURE 5 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 6 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
  • FIGURE 7 CELL-FREE PROTEIN SYNTHESIS MARKET SIZE VALIDATION FROM INDUSTRY EXPERTS
  • FIGURE 8 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 9 GLOBAL CELL-FREE PROTEIN SYNTHESIS MARKET: CAGR PROJECTIONS (2025-2030)
  • FIGURE 10 CELL-FREE PROTEIN SYNTHESIS MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 CELL-FREE PROTEIN SYNTHESIS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 CELL-FREE PROTEIN SYNTHESIS MARKET, BY WORKFLOW, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 CELL-FREE PROTEIN SYNTHESIS MARKET, BY METHOD, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 CELL-FREE PROTEIN SYNTHESIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 CELL-FREE PROTEIN SYNTHESIS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 REGIONAL SNAPSHOT OF CELL-FREE PROTEIN SYNTHESIS MARKET
  • FIGURE 17 INCREASING DEMAND FOR RAPID PROTEIN SYNTHESIS FOR RESEARCH AND THERAPEUTIC APPLICATIONS TO PROPEL MARKET GROWTH
  • FIGURE 18 US AND ENZYME ENGINEERING SEGMENT COMMANDED LARGEST MARKET SHARES IN 2024
  • FIGURE 19 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 20 CELL-FREE PROTEIN SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 REVENUE SHIFT IN CELL-FREE PROTEIN SYNTHESIS MARKET
  • FIGURE 22 VALUE CHAIN ANALYSIS: PRODUCT DEVELOPMENT AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • FIGURE 23 CELL-FREE PROTEIN SYNTHESIS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 24 CELL-FREE PROTEIN SYNTHESIS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 25 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR CELL-FREE PROTEIN SYNTHESIS PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF CELL-FREE PROTEIN SYNTHESIS BASED ON OFFERINGS
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 28 NORTH AMERICA: CELL-FREE PROTEIN SYNTHESIS MARKET SNAPSHOT
  • FIGURE 29 ASIA PACIFIC: CELL-FREE PROTEIN SYNTHESIS MARKET SNAPSHOT
  • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET, 2022-2024 (USD MILLION)
  • FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL-FREE PROTEIN SYNTHESIS MARKET, 2024
  • FIGURE 32 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 33 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 34 CELL-FREE PROTEIN SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 35 EV/EBITDA OF KEY VENDORS
  • FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 37 CELL-FREE PROTEIN SYNTHESIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 39 GENSCRIPT: COMPANY SNAPSHOT
  • FIGURE 40 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)